News – Page 493 – Endpoints News

Pfizer and BioNTech hit back against CureVac suit over Covid-19 vaccine patents

3 years ago

MarketingRx roundup: Myovant, Pfizer launch first Myfembree ads; IPG Health gathers medcomm agencies

3 years ago

Q&A: CMO and development chief Dietmar Berger says Sanofi is 'right there at the table' on diversity efforts

3 years ago

In another accelerated approval quest, Biogen will send its ALS drug to the FDA despite inconclusive data

3 years ago

As Merck buyout buzz heats up, Seagen touts a positive update on their Padcev/Keytruda combo

3 years ago

J&J looks to expand Rybrevant lung cancer indication to larger EGFR-positive population

3 years ago

RA Capital jumps on board diabetes biotech, pitching in on $160M Series D

3 years ago

Galectin gets $60M credit line from billionaire chair; Inflammatory disease biotech reaches SPAC deal

3 years ago

Lifetime pharma ban? ‘Pharma Bro’ returns with ‘software’ company for drug discovery

3 years ago

'Go quickly': Amgen R&D vet Dirk Nagorsen jumps to a startup with big plans for TCRs

3 years ago

Targeting BioMarin's new drug franchise, BridgeBio CEO Neil Kumar celebrates an interim win. But is it good enough?

3 years ago

Following a host of trial flops, Angion halts R&D work, searches for ‘strategic alternatives’

3 years ago

Legend seeks $250M after positive #ASCO22 data, but challenges remain for the J&J partner

3 years ago

Tonix scraps Covid-19 licensing deal after just three months — shares spike

3 years ago

Drug developer sues FDA over delayed decision on narcolepsy drug

3 years ago

Novartis returns to appellate court, requesting rehearing and reversal in Gilenya patent case

3 years ago

Turkey loses bid at WTO demanding all foreign pharma companies make drugs locally

3 years ago

Drug manufacturers are fighting mad about pricing legislation and they're taking the next round public

3 years ago

Former FBI trainee charged with insider trading scheme ahead of Merck-Pandion buyout

3 years ago

Out-of-pocket cap will increase the net price of insulin, CBO tells Senate bill sponsors

3 years ago

Caught with insider trading, former Five Prime investigator makes case for light sentence

3 years ago

Pfizer considers antiviral options as Paxlovid use skyrockets amid worries of resistance

3 years ago

Takeda casts familiar fixture for IBD patients in latest Entyvio campaign

3 years ago

Ginkgo Bioworks acquires struggling synbio rival Zymergen in $300M all-stock deal

3 years ago

First page Previous page 490 491 492493494 495 496 Next page Last page